ONCSQ (OncoSec Medical) Pretax Margin %: % (As of Jan. 2023)


What is OncoSec Medical Pretax Margin %?

OncoSec Medical ONCSQ -99.00% Pretax Margin % is % as of Jan. 2023.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. OncoSec Medical's Pre-Tax Income for the three months ended in Jan. 2023 was $-6.86 Mil. OncoSec Medical's Revenue for the three months ended in Jan. 2023 was $0.00 Mil. Therefore, OncoSec Medical's pretax margin for the quarter that ended in Jan. 2023 was %.

The historical rank and industry rank for OncoSec Medical's Pretax Margin % or its related term are showing as below:


ONCSQ's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

OncoSec Medical  (OTCPK:ONCSQ) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

OncoSec Medical Pretax Margin % Related Terms

OncoSec Medical Pretax Margin % Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Pretax Margin % Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ONCSQ vs NOVNQ, USRM, VRTX: Pretax Margin % Comparison

For the Biotechnology subindustry, OncoSec Medical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSec Medical Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoSec Medical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where OncoSec Medical's Pretax Margin % falls into.


OncoSec Medical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

OncoSec Medical's Pretax Margin for the fiscal year that ended in Jul. 2022 is calculated as

Pretax Margin=Pre-Tax Income (A: Jul. 2022 )/Revenue (A: Jul. 2022 )
=-37.514/0
= %

OncoSec Medical's Pretax Margin for the quarter that ended in Jan. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2023 )/Revenue (Q: Jan. 2023 )
=-6.858/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
OncoSec Medical (ONCSQ) has a Pretax Margin % of % as of Jan. 2023. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Pretax Margin % too high?
OncoSec Medical's current Pretax Margin % is %.
How does OncoSec Medical's Pretax Margin % compare to NOVNQ and USRM?
OncoSec Medical's Pretax Margin % of % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Pretax Margin % is % as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.